Research Article
Molecular Targeted Approaches for Advanced BRAF V600, N-RAS, c-KIT, and GNAQ Melanomas
Table 2
Patients treated with BRAF inhibitors: frequencies of side effects.
| Side effects | Frequency (%) |
| Arthralgia | 54% | Nausea | 34% | Skin erythema | 28% | Vomiting | 14% | Headache | 13% | Fatigue | 11% | Keratoacanthomas | 2% | Hypertransaminasemia | 2% | Alopecia | 1% | QTc prolongation | 1% |
|
|